Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Somatostatin ; related peptides
Patent
1995-06-05
1997-01-28
Davenport, Avis M.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Somatostatin ; related peptides
530317, 530324, 530328, 530327, A61K 3800, C07K 500, C07K 700
Patent
active
055978940
ABSTRACT:
Disclosed are methods and compositions for the diagnosis and treatment of diseases associated with aberrant expression of a somatostatin receptor (e.g., cancer) or with increased production of a factor regulatable by somatostatin (e.g., acromegaly). The compounds of the invention are of the general formulae: ##STR1## wherein P is a somatostatin peptide analog which binds to a somatostatin receptor,
REFERENCES:
patent: 4133782 (1979-01-01), Vale, Jr. et al.
patent: 4146612 (1979-03-01), Veber
patent: 4190648 (1980-02-01), Veber
patent: 4211693 (1980-07-01), Rivier et al.
patent: 4224190 (1980-09-01), Villadsen et al.
patent: 4230617 (1980-10-01), Sarantakis
patent: 4235886 (1980-11-01), Freidinger et al.
patent: 4238481 (1980-12-01), Rink et al.
patent: 4291022 (1981-09-01), Sandrin et al.
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 4316890 (1982-02-01), Kamber et al.
patent: 4328214 (1982-05-01), Rink et al.
patent: 4358439 (1982-11-01), Sieber et al.
patent: 4360516 (1982-11-01), Freidinger et al.
patent: 4369179 (1983-01-01), Rink et al.
patent: 4395403 (1983-07-01), Bauer et al.
patent: 4435385 (1984-03-01), Bauer et al.
patent: 4485101 (1984-11-01), Coy et al.
patent: 4486415 (1984-12-01), Freidinger
patent: 4522813 (1985-06-01), Nutt
patent: 4585755 (1986-04-01), Morgan et al.
patent: 4603120 (1986-07-01), Kamber
patent: 4650787 (1987-03-01), Schally et al.
patent: 4684620 (1987-08-01), Hruby et al.
patent: 4725577 (1988-02-01), Schally et al.
patent: 4801803 (1989-01-01), Denen et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 4871717 (1989-10-01), Coy et al.
patent: 4889991 (1989-12-01), Ramsey et al.
patent: 4904642 (1990-02-01), Coy et al.
patent: 5008546 (1991-04-01), Mazziotta et al.
patent: 5070878 (1991-12-01), Denen
patent: 5462926 (1995-10-01), Coy et al.
Sayers et al., "An improved technique for the preparation of isolated rat adrenal cells: a sensitive, accurate and specific method for the assay of ACTH," 1971, Endocrinology 88:1063-1068.
Munson et al., "ligand: a versatile computerized approach for characterization of Ligand-binding systems," 1980, Anal. Biochem. 107:220-239.
McPherson, "Analysis of radioligand binding experiements," 1985, J. of Pharm. Meth. 14:213-228.
Ben-Jonathan et al., "Optimization of culture conditions for short-term pituitary cell culture," 1983, Methods in Enzymology 103:249-257.
Hoefer et al., "Prolactin secretion by cultured anterior pituitary cells: influence of culture conditions and endocrine status of the pituitary donor," 1984, Mol. Cell. Endocrin. 35:229-235.
Hanks et al., "Peptides and the blood-brain barrier: Lipophilicity as a predictor of permeability," 1985, Brain Res. Bull. 15:287-292.
Heiman et al., "An extremely sensitive in vitro model for elucidating structure-activity relationships of growth hormone-releasing factor analogs," 1985, Endocrinology 116(1)410-415.
Van Binst et al., "Backbone modifications in somatostatin analogues: relation between conformation and activity," 1992, Peptide Res. 5(1):8-13.
Prevost et al., "Molecular heterogeneity of somatostatin analogue BIM-23014C receptors in human breast carcinoma cells using the chemical cross-linking assay," 1992, Cancer Res. 52:843-850.
Yamada et al., "Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney," 1992, Proc. Natl. Acad. Sci. USA 89:251-255.
Raynor et al., "Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides," 1993, Mol. Pharmacol. 43:838-844.
Krenning et al., "Somatostatin receptor scintigraphy with [.sup.111 in-DTPA-d-Phe.sup.1 ]- and [.sup.123 I-Tyr.sup.3 ]-octreotide: the Rotterdam experience with more than 1000 patients," 1993, Eur. J. Nuc. Med. 20(8):716-731.
Rohrer et al., "Cloning and characterization of a fourth human somatostatin receptor," 1993, Proc. Natl. Acad. Sci. USA 90:4196-4200.
O'Dorisio et al., "Characterization of somatostatin receptors on human neuroblastoma tumors," 1994, Cell Growth and Differentiation 5:1-8.
Patel et al., "All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase," 1994, Biochem. Biophys. Res. Commun. 198(2):605-612.
Fisher et al., "Radiation dosimetry for radioimmunotherapy," 1994, Cancer 73(3):905-911.
Reubi et al., "Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in Situ hybridization," 1994, Cancer Res. 54:3455-3459.
Coy David H.
Murphy William A.
O'Dorisio M. Sue
O'Dorisio Thomas M.
Woltering Eugene A.
Children's Hospital, Inc.
Davenport Avis M.
The Administrators of the Tulane Educational Fund
The Louisiana State University Medical Center Foundation
The Ohio State University Research Foundation
LandOfFree
Multi-tyrosinated somatostatin analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multi-tyrosinated somatostatin analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multi-tyrosinated somatostatin analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-942088